Hims & Hers Health (HIMS) Net Margin (2020 - 2026)

Hims & Hers Health has disclosed Net Margin across 7 years of filings, most recently posting 15.15% for Q1 2026.

• Net Margin for Q1 2026 came in at 15.15%, down 2359.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.56% (down 977.0% YoY), and the FY2025 annual result was 5.47%, down 307.0% from the prior year.
• Net Margin came in at 15.15% for Q1 2026 at Hims & Hers Health, down from 3.33% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 18.82% in Q3 2024 to a low of 17.33% in Q2 2022.
• The 5-year median for Net Margin is 0.5% (2023), against an average of 1.47%.
• Across the five-year window, Net Margin soared 8222 bps in 2022 and tumbled 2359 bps in 2026, its largest moves.
• Hims & Hers Health's Net Margin stood at 6.52% in 2022, then soared by 108 bps to 0.5% in 2023, then soared by 971 bps to 5.41% in 2024, then sank by 38 bps to 3.33% in 2025, then sank by 554 bps to 15.15% in 2026.
• The last three Net Margin figures came in at 15.15% (Q1 2026), 3.33% (Q4 2025), and 2.63% (Q3 2025), per Business Quant data.